logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Toshimi Takano

the cancer institute hospital of japanese foundation for cancer research
H指数:36
被引数:8,055

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world event-free survival with neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab in early-stage triple-negative and estrogen receptor-low, HER2-negative breast cancer

早期三阴性及雌激素受体低表达、HER2阴性乳腺癌患者接受新辅助 pembrolizumab 联合化疗及辅助 pembrolizumab 治疗的真实世界无事件生存情况

BMC Cancer
IF3.4
2026-10-060
OAAI
Yosuke Aoyama; Yukinori Ozaki; Masahiro Kuno; Jun Masuda; Meiko Nishimura; Mami Kurata; Lina Inagaki; Mari Hosonaga; Ippei Fukada; Emi Taniguchi; Yuri Kimura; Tetsuyo Maeda; Kazuyo Yoshida; Nami Yamashita; Takayuki Kobayashi; Toshimi Takano; Takayuki Ueno
E7389-LF as a first-line chemotherapy for patients with metastatic/advanced HER2-negative breast cancer: results from the phase 1 dose-expansion part of study 114

E7389-LF作为HER2阴性转移性/晚期乳腺癌患者的一线化疗方案：研究114第1期剂量扩展部分的结果

Breast Cancer Research
IF5.6
2026-09-170
OAAI
Hiroshi Ishiguro; Yasuo Miyoshi; Hiroyuki Yasojima; Junichiro Watanabe; Toshimi Takano; Akihiko Shimomura; Eriko Tokunaga; Toru Mukohara; Yasuto Naoi; Daiko Matsuoka; Shiori Okumura; Yohei Otake; Takuya Suzuki; Takao Takase; Taro Semba; Ziming Zhao; Kan Yonemori
Real-world characteristics of trastuzumab deruxtecan-related interstitial lung disease in Japanese patients with breast cancer and gastric cancer

日本乳腺癌和胃癌患者中曲妥珠单抗德鲁克替康相关间质性肺疾病的真实世界特征

Oncologist
IF4.2
2026-09-070
OAAI
Yutaka Fujiwara; Katsunori Oikado; Tomohisa Baba; Masahiko Kusumoto; Shinichi Sasaki; Masahiro Endo; Terufumi Kato; Yasuyuki Kurihara; Yoshinobu Saito; Kunihiro Yagihashi; Masafumi Sata; Yoshinao Sato; Hirotsugu Kenmotsu; Taiki Fukuda; Teppei Yamaguchi; Saiko Isshiki; Hiroshi Wakui; Haruki Kobayashi; Satoshi Ikeda; Motoyasu Kato; Ou Yamaguchi; Toshimi Takano; Ken Kato; Yoshiharu Hiruma; Koji Hirata; Wataru Hashimoto; Kazuyoshi Kuwano
Real-world outcomes of datopotamab deruxtecan after trastuzumab deruxtecan in hormone receptor–positive, HER2-negative metastatic breast cancer

曲拉妥单抗德鲁克替康后，在激素受体阳性、HER2阴性转移性乳腺癌中的真实世界结局

Breast Cancer
IF2.9
2026-09-020
OAAI
Yosuke Aoyama; Yukinori Ozaki; Masahiro Kuno; Rika Kizawa; Jun Masuda; Meiko Nishimura; Mami Kurata; Lina Inagaki; Mari Hosonaga; Ippei Fukada; Tetsuyo Maeda; Kazuyo Yoshida; Nami Yamashita; Takayuki Kobayashi; Toshimi Takano; Takayuki Ueno
Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE

曲妥珠单抗德鲁替康再次治疗在HER2阳性转移性乳腺癌中的应用：EN-SEMBLE

Breast
IF7.9
2026-08-010
PRE
Nozawa, Kazuki; Iwata, Hiroji; Mukohara, Toru; Taira, Tetsuhiko; Yoshimura, Akiyo; Nagai, Shigenori E.; Hashimoto, Jun; Matsuura, Kazuo; Mizuno, Toshiro; Shinden, Yoshiaki; Yamamoto, Mitsugu; Takano, Toshimi; Wakahara, Makoto; Terakawa, Hirofumi; Yamanaka, Takashi; Kojima, Yasuyuki; Nakayama, Takahiro; Hirakawa, Yuji; Shiosakai, Kazuhito; Tsurutani, Junji
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10

TroFuse-011研究设计：sacituzumab tirumotecan联合或不联合pembrolizumab治疗PD-L1 CPS<10的晚期三阴性乳腺癌

Future Oncology
IF2.6
2026-07-310
OA
Hope S. Rugo; Peter Schmid; Javier Cortes; Toshimi Takano; Peter A. Fasching; Yeon Hee Park; Giampaolo Bianchini; Sandra Ximena Franco; Cynthia Villarreal-Garza; Olivier Tredan; Yongmei Yin; Romualdo Barroso-Sousa; Xuan Peng; Usha Malhotra; Karen Lisa Smith; Aditya Bardia
Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study

日本青少年及年轻晚期实体瘤患者中的胚系致病变异：一项全国性肿瘤-正常配对测序研究

International Journal of Clinical Oncology
IF2.8
2026-07-270
PRE
Kota Ishioka; Naomi Hayashi; Naoki Miyazaki; Akito Dobashi; Eri Habano; Asami Kuga; Keika Kaneko; Hiromi Arakawa; Yuko Minoura; Ippei Fukada; Masumi Yamazaki; Naoki Fukuda; Akemi Kataoka; Toshimi Takano; Masayuki Watanabe; Shunji Takahashi; Arisa Ueki; Makiko Ono
Eribulin versus taxane as first-line chemotherapy combined with dual HER2 blockade in patients with HER2-positive locally advanced or metastatic breast cancer: final survival outcomes of the JBCRG-M06/EMERALD study☆

艾瑞布林与紫杉烷类作为HER2阳性局部晚期或转移性乳腺癌患者的一线化疗联合双HER2阻断治疗的比较：JBCRG-M06/EMERALD研究的最终生存结果☆

ESMO Open
IF8.3
2026-07-210
OAAI
S. Saji; T. Yamashita; J. Tsurutani; Y. Sagara; H. Shigematsu; T. Takano; M. Takahashi; K. Araki; N. Tamura; M. Tsuneizumi; T. Morimoto; S. Yanai; A. Kato; M. Yamaguchi; S. Kubo; Y. Hasegawa; E. Tokunaga; H. Hasegawa; S. Osaka; S. Morita
Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B)

阿贝西利在激素受体阳性、HER2阴性转移性乳腺癌患者中，在阿贝西利联合内分泌治疗进展后的再次挑战：来自II期again研究（WJOG14220B）的结果

Breast Cancer Research and Treatment
IF3
2026-07-200
OA
Meiko Nishimura; Takahiro Kogawa; Keiji Sugiyama; Yukinori Ozaki; Yuko Tanabe; Chikako Funasaka; Sasagu Kurozumi; Akiyo Yoshimura; Tsutomu Iwasa; Hitomi Sakai; Mitsunori Morita; Satomi Watanabe; Takaaki Fujii; Mitsugu Yamamoto; Yasushi Tsuji; Mitsuo Terada; Takayo Ota; Shinya Tokunaga; Mototsugu Shimokawa; Toshimi Takano
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial

接受帕妥珠单抗再治疗患者的生活质量：PRECIOUS试验的二次分析

Breast
IF7.9
2026-05-230
OAAI
Taira, Naruto; Yamamoto, Yutaka; Iwata, Hiroji; Saji, Shigehira; Takahashi, Masato; Yoshinami, Tetsuhiro; Ueno, Takayuki; Toyama, Tatsuya; Takano, Toshimi; Kashiwaba, Masahiro; Tsugawa, Koichiro; Tada, Hiroshi; Hara, Fumikata; Fujisawa, Tomomi; Niikura, Naoki; Morita, Satoshi; Masuda, Norikazu
BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B)

BRCA1/2逆转突变在日本接受奥拉帕利治疗后进展的转移性乳腺癌患者中的研究：OLIVE (WJOG15321B)

Breast Cancer
IF2.9
2026-04-100
OAAI
Hitomi Sakai; Rika Kusumoto-Matsuo; Mari Hosonaga; Kazuki Nozawa; Manabu Futamura; Yuko Tanabe; Toru Mukohara; Kazuhiro Shiraishi; Tatsuya Toyama; Hiroyuki Yasojima; Noriyuki Watanabe; Hideki Sakai; Tsutomu Iwasa; Nobumichi Takeuchi; Hiroshi Tada; Kazuko Sakai; Natsuko Chiba; Toshimi Takano; Junji Tsurutani
Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B)

多基因检测（MammaPrint/Blueprint）预测激素受体阳性、HER2阴性乳腺癌早期复发的特征：一项病例对照研究（WJOG16722B）

Breast Cancer
IF2.9
2026-03-260
OAAI
Rurina Watanuki; Hitomi Sakai; Yuri Kimura; Atsushi Yoshida; Yukinori Ozaki; Akemi Kataoka; Natsue Uehiro; Atsushi Fushimi; Hidenori Kamio; Takashi Ikeno; Masashi Wakabayashi; Mayumi Iida; Tsutomu Kawaguchi; Junji Tsurutani; Toshimi Takano
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort

糖皮质激素在粒细胞集落刺激因子相关大血管血管炎中很少需要：日本癌症中心队列

RHEUMATOLOGY
IF4.4
2025-12-010
PRE
Morita, Yuka; Takeda, Koichi; Osumi, Hiroki; Aoyama, Yosuke; Fukuda, Naoki; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Ogura, Mariko; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shinozaki, Eiji; Takano, Toshimi; Shiga, Taro; Yamaguchi, Kensei
Characterizing heterogeneous cis-regulatory elements in gene regulatory programs associated with breast cancer

表征与乳腺癌相关的基因调控程序中的异质性顺式调控元件

Genome Medicine
IF11.2
2025-11-270
OAAI
Chisa Hori; Kohei Kumegawa; Sumito Saeki; Yoko Takahashi; Liying Yang; Tomoyoshi Nakadai; Kazutaka Otsuji; Chikako Takahata; Yukinori Ozaki; Natsue Uehiro; Yurie Haruyama; Tomo Osako; Toshimi Takano; Seiichi Mori; Tetsuo Noda; Satoshi Fujii; Shinji Ohno; Takayuki Ueno; Reo Maruyama
HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy

HER2DX在HER2阳性早期乳腺癌老年患者中的应用：来自RESPECT试验中曲妥珠单抗±化疗的扩展随访研究

Nature Communications
IF15.7
2025-11-040
OAAI
Kazuki Nozawa; Masataka Sawaki; Yukari Uemura; Michiko Tsuneizumi; Toshimi Takano; Naomi Gondo; Fumikata Hara; Michiko Harao; Tatsuya Toyama; Naruto Taira; Ana Vivancos; Charles M. Perou; Esther Sanfeliu; Fara Brasó-Maristany; Joel S. Parker; Wesley Buckingham; Laia Paré; Guillermo Villacampa; Mercedes Marín-Aguilera; Patricia Villagrasa; Aleix Prat; Hiroji Iwata

研究方向

暂未获取到该数据
Y
Yukinori Ozaki
H 指数:16论文数:154被引数:835
N
Norikazu Masuda
H 指数:64论文数:698被引数:2.9万
J
Junji Tsurutani
H 指数:53论文数:366被引数:1.8万
S
Shinji Ohno
H 指数:62论文数:565被引数:2.3万
M
Masakazu Toi
H 指数:2论文数:8被引数:461
S
Satoshi Morita
H 指数:85论文数:1,270被引数:4.0万
T
Takayuki Ueno
H 指数:42论文数:395被引数:7,257
Y
Yuko Tanabe
H 指数:30论文数:225被引数:2,760
Y
Yuji Miura
H 指数:29论文数:349被引数:4,369
H
Hidetaka Kawabata
H 指数:17论文数:126被引数:1,356